Table 1. Patient information.
| ID# | Age (Years) | Gender | EWSR FISH | Localized/Metastatic |
|---|---|---|---|---|
| 1 | 16 | M | + | Metastatic |
| 8 | 6 | F | + | Localized |
| 9 | 9 | F | + | Metastatic |
| 13 | 1.6 | F | + | Localized |
| 14 | 6 | M | + | Metastatic |
| 16 | 12 | F | + | Localized |
| 18 | 15 | F | + | Localized |
| 20 | 6 | F | + | Metastatic |
| 23 | 16 | F | + | Metastatic |
| 25 | 17 | M | + | Localized |
| 026785 | 3 | M | NA | NA |
| 236786 | 20 | M | NA | NA |
| 026839 | 2 | F | NA | NA |
| 026940 | 11 | F | NA | NA |
| 027153 | 20 | M | NA | NA |
| 027161 | 18 | M | NA | NA |
Ten (10) pediatric ESFT patients and 6 non-oncology pediatric patients were utilized for the analysis Ewing Sarcoma derived small extracellular vesicles (sEV).